MAKE SURE YOUR DENTIST IS AN ADA MEMBER!: ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST! Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY

2025 Ninth District President

Dr. Renuka Bijoor

ADA Update: a new login experience

We’re updating how you log in to your NYSDA and ADA account.

RENEW YOUR MEMBERSHIP TODAY!

3 EASY WAYS TO PAY 1 ONLINE: nysdental.org/renew 2 MAIL: Return dues stub and payment 3 PHONE: 1-800-255-2100

Member Assistance Program (MAP)

Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.

Welcome to the Ninth District Dental Association

The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.

In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.

The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.



Don't Forget to Register!! OPEN TO ALL MEMBERS!

9th District Social Event
Celebrating Frills & Drills

Wednesday, June 4, 2025

6:30-9:00 pm

ST. ANDREWS GOLF CLUB
10 Old Jackson Avenue
Hastings-on-Hudson, NY 10706

There will be a buffet, passed hors d'oeuvres, beer & wine, a cash bar, vendors, and lots of fun FOR ALL MEMBERS!

And a Keynote Lecture:  Leadership, High Performance & Mindset Mastery for the Female Clinician.
In this transformative session, Allison Lacoursiere explores the integration of feminine and masculine energies in leadership, revealing how balancing these forces unlocks extraordinary performance and sustainable success.  Through an engaging examination of neuroscience-based communication techniques and actionable insights into personal leadership, participants will learn to harness their unique strengths, elevate their professional presence, and master the mindset needed to thrive both clinically and personally.

Ms. Allison Lacoursiere is a certified, professional coach, high-performance expert, and transformational speaker dedicated to empowering clinicians and leaders.  With a dynamic blend of neuroscience-backed strategies, feminine and masculine energy principles, and powerful communication frameworks, Allison guides dental professionals toward unprecedented personal and professional growth.

Co-Sponsors

Bank of America, Practice Solutions

Danziger & Markhoff LLP*

DDSMatch


MLMIC Insurance Company*

We hope to see you there!

Renuka Bijoor, D.D.S., M.P.H.
President & Chair, Frills & Drills Subcommittee


 


Latest News Around the Tripartite

NIH Issues Research Showing Smoking Cessation Pill May Help Youth Quit Vaping

May 6, 2025

Per the notice below, the National Institutes of Health (NIH) has issued research that shows a smoking cessation pill could help youth in quitting vaping.

Smoking cessation pill may help youth quit vaping

At a Glance

  • Teens and young adults who took a smoking cessation drug called varenicline were more likely to quit vaping nicotine than those who got a placebo pill.
  • The results suggest that this existing treatment for nicotine addiction could help combat e-cigarette use among young people.

Vaping devices have become the most commonly used form of nicotine among youth in the United States.  About 1 in 4 young adults between the ages of 18 and 25 regularly use e-cigarettes to vape nicotine, as well as 7% of U.S. high school students.  The growing popularity of vaping has reversed earlier progress in curbing nicotine addiction, which primes young brains for other forms of substance use and comes with its own health risks.  While many young people who vape say they want to quit or cut back, studies hadn’t tested treatments that might help them succeed.

NIH-funded researchers led by Dr. A. Eden Evins at Massachusetts General Hospital wanted to know if an FDA-approved smoking cessation drug called varenicline could help youth quit nicotine vaping.  The drug, which is approved for smoking cessation in adults, works by blocking some effects of nicotine in the brain.  As a result, it can ease quitting by both reducing craving and making nicotine less enjoyable.  Earlier studies have shown mixed results for the medication in helping youth who want to stop smoking.

To test its use for vaping, the researchers enrolled 261 participants who ranged in age from 16 to 25, with an average age of about 21.  The participants reported nicotine vaping almost daily with no history of regular tobacco smoking.  Trial results appeared in JAMA on April 23, 2025.  Participants were randomly assigned to one of three groups.  All got referred to an intervention called This is Quitting, a free text messaging-based program to encourage vaping cessation.  In addition, two groups received 20-minute, remote weekly sessions with a young, nonprofessional counselor trained to help youth stop vaping.  One of these two groups took varenicline twice a day while the other took an inactive placebo pill.  After 12 weeks, 51% of those taking varenicline had stopped vaping.  Only 14% of those taking the placebo pill and just 6% of those who received only a referral for text-based support stopped vaping.  By six months, 28% of those who took varenicline still weren’t vaping compared to 7% of those who took the placebo and 4% of those in the text-only group.

The researchers found that varenicline was well tolerated, causing no serious side effects.  Only three participants dropped out of the study due to adverse events—two taking varenicline and one taking the placebo.  Importantly, study participants who quit vaping didn’t replace their vaping with smoking tobacco.  More long-term study is needed, including in young people who vape and smoke tobacco and in younger teens who vape nicotine.  But the findings suggest that varenicline could help to address nicotine use and vaping among teens and young adults.  Because varenicline is approved for smoking cessation, doctors can and do already prescribe it to children and teens.

“Vaping is extremely popular among kids, and we know that this early nicotine exposure can make drugs like cocaine more addictive down the line, yet ours is the first treatment study to look at this vulnerable population,” Evins says.  “We wanted to help teens and young adults quit, and we found that prescribing varenicline is the best way to do that.”

Related Links

References: Varenicline for Youth Nicotine Vaping Cessation: A Randomized Clinical Trial.  Evins AE, Cather C, Reeder HT, Evohr B, Potter K, Pachas GN, Gray KM, Levy S, Rigotti NA, Iroegbulem V, Dufour J, Casottana K, Costello MA, Gilman JM, Schuster RM.  JAMA.  2025 Apr 23:e253810.  doi: 10.1001/jama.2025.3810.  Epub ahead of print.  PMID: 40266580.

Funding: NIH’s National Institute on Drug Abuse (NIDA).


Latest News Around the Ninth


Around the Ninth District